Indian, German firms to collaborate on immunoglobulin products: Indian Embassy
The Indian mission facilitated the exchange of a non-disclosure agreement (NDA) between Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd. on the sidelines of the Indo-German Health Leadership Dialogue on October 13, says Embassy of India in Berlin
An Indian and German company plan to collaborate on the manufacturing and commercialization of immunoglobulin products, with technology transfer to India, according to the Indian Embassy in Berlin. The embassy facilitated the exchange of a non-disclosure agreement between Germany's Neovii Biotech GmbH and India's VINS Bioproducts Ltd. The collaboration will focus on immunoglobulin products, including anti-thymocyte globulin, used in organ transplantation and treating specific blood disorders.
The agreement is expected to enhance India's capabilities in specialized biological products and decrease dependence on imports.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
